AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,670 | -28.0% | 16,829 | -38.1% | 0.00% | – |
Q2 2023 | $24,539 | +5.7% | 27,199 | -34.3% | 0.00% | – |
Q1 2023 | $23,209 | -41.0% | 41,415 | -39.2% | 0.00% | – |
Q4 2022 | $39,313 | +78.7% | 68,133 | 0.0% | 0.00% | – |
Q3 2022 | $22,000 | +46.7% | 68,133 | +59.2% | 0.00% | – |
Q2 2022 | $15,000 | -6.2% | 42,792 | +95.7% | 0.00% | – |
Q1 2022 | $16,000 | -66.7% | 21,863 | +2.7% | 0.00% | – |
Q4 2021 | $48,000 | -7.7% | 21,280 | +2.3% | 0.00% | – |
Q3 2020 | $52,000 | -93.0% | 20,800 | -61.7% | 0.00% | -100.0% |
Q2 2020 | $738,000 | -4.2% | 54,334 | -46.5% | 0.00% | 0.0% |
Q1 2020 | $770,000 | +234.8% | 101,622 | +179.0% | 0.00% | +100.0% |
Q4 2019 | $230,000 | – | 36,420 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |